Low Dose Naltrexone (LDN) Mega Study
Contents
Low Dose Naltrexone (LDN)
Low Dose Naltrexone (LDN)

Related

A
Count
A
Treatments
A
Outcomes
A
User Variables 1
A
Measurements 1

Tags

Low Dose Naltrexone
LDN
Low Dose Naltrexone (LDN)

Treatment Effectiveness

User reported effectiveness ratings Low Dose Naltrexone (LDN) for various conditions.

Conditions Major Improvement Moderate Improvement Much Worse No Effect Worse Responses
Back Pain 20% 30% 0% 40% 10% 10
Neck Pain 0% 0% 0% 100% 0% 1
Allergies 31% 50% 0% 19% 0% 16
Crohn's Disease 67% 20% 3% 10% 0% 30
Dandruff 25% 25% 25% 25% 0% 4
Depression 35% 29% 6% 18% 12% 17
Dermatillomania (Compulsive Skin Picking) 0% 50% 0% 0% 50% 2
Food Sensitivity 67% 0% 0% 33% 0% 3
Hypoglycemia 100% 0% 0% 0% 0% 1
Migraine 30% 0% 0% 60% 10% 10
Multiple Chemical Sensitivity (MCS) 50% 25% 0% 25% 0% 4
Multiple Sclerosis 50% 32% 2% 14% 3% 125
Neurological Problems and Chronic Pain 43% 19% 0% 29% 10% 21
Neuropathy 30% 20% 5% 45% 0% 20
Nickel Allergy 100% 0% 0% 0% 0% 1
Night Cramps 0% 60% 20% 20% 0% 5
Osteoarthritis 20% 20% 0% 60% 0% 5
Overactive Bladder 100% 0% 0% 0% 0% 1
Palindromic Rheumatism 0% 100% 0% 0% 0% 1
Premenstrual Syndrome (PMS) 0% 25% 0% 75% 0% 4
Psoriasis 57% 29% 0% 14% 0% 7
Rheumatoid Arthritis 48% 48% 0% 5% 0% 21
Rosacea 0% 0% 0% 100% 0% 1
Ulcerative Colitis 46% 23% 0% 31% 0% 13
Urinary Incontinence 0% 33% 0% 67% 0% 3
Vertigo 100% 0% 0% 0% 0% 1
Vulvar Vestibulitis 0 0 0 0 0 0
Fatigue 27% 33% 3% 28% 9% 93
Raynaud's Disease 17% 33% 0% 33% 17% 6
Hashimoto's Disease 33% 33% 11% 22% 0% 9

Side Effects

User-reported side effects of Low Dose Naltrexone (LDN)

Side Effect Percent of Reports Low Dose Naltrexone (LDN)
Hypothyroidism 5%
Body Aches 23%
Difficulty Sleeping 34%
Drowsiness 25%
Increased Self-Confidence 44%
Increased Sense of Well-Being 55%
Increased Sex Drive 18%
Muscle Ache 23%
Sore Joints 21%
Ulcer 10%
Vivid Dreams 46%

Below is the degree of change seen after Low Dose Naltrexone (LDN) is higher than average.

Outcomes
of
Below is the change in the listed outcome after is higher than average.
Sort by Effect Size
Sort by Confidence
% Change from Baseline*
*
Change in the listed outcome after is higher than average.

Low Dose Naltrexone (LDN) Info

Property Value
Variable Name Low Dose Naltrexone (LDN)
Aggregation Method SUM
Analysis Performed At 2020-10-07
Duration of Action 21 days
Filling Value 0
Kurtosis 0.5
Mean 0.5 count
Median 0.5 count
Minimum Allowed Value 0 count
Number of Aggregate Predictors 0
Number of Aggregate Outcomes 0
Number of Measurements 1
Number of Measurements (including those generated by tagged, joined, or child variables) 1
Public true
Onset Delay 30 minutes
Standard Deviation 0.70710678118655
Unit Count
User Variables 1
Variable Category Treatments
Variable ID 94246
Variance 0.5